YARROW BIOSCIENCE, INC. Lease Obligation Incurred
YARROW BIOSCIENCE, INC. (YARW) reported Lease Obligation Incurred of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2025-03-06
- YARROW BIOSCIENCE, INC. lease obligation incurred for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. lease obligation incurred for the quarter ending 2024-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. lease obligation incurred for the quarter ending 2024-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. lease obligation incurred for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. lease obligation incurred for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- YARROW BIOSCIENCE, INC. lease obligation incurred for fiscal 2023 was $214.00K.
- YARROW BIOSCIENCE, INC. lease obligation incurred for fiscal 2022 was $0.00.
- YARROW BIOSCIENCE, INC. lease obligation incurred for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $65.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $65.00K derived: sum of 3 quarters · filed 2025-03-06 | $65.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $65.00K derived: sum of 2 quarters · filed 2025-03-06 | $65.00K derived: sum of 3 quarters · filed 2025-03-06 | $65.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $65.00K derived: sum of 2 quarters · filed 2025-03-06 | $65.00K derived: sum of 3 quarters · filed 2025-03-06 | $214.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $149.00K 10-Q · filed 2024-11-07 | $149.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $149.00K 10-Q · filed 2024-08-14 | $149.00K derived: sum of 3 quarters · filed 2024-08-14 | $149.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $149.00K 10-Q · filed 2024-05-09 | $149.00K derived: sum of 2 quarters · filed 2024-05-09 | $149.00K derived: sum of 3 quarters · filed 2024-05-09 | $149.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $0.00 derived: sum of 3 quarters · filed 2024-03-01 | $0.00 10-K · filed 2024-03-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2023-08-14 | $0.00 derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | $0.00 derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $230.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $230.00K derived: sum of 3 quarters · filed 2022-03-17 | $230.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $230.00K derived: sum of 2 quarters · filed 2022-03-17 | $230.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.06M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $230.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.06M derived: sum of 3 quarters · filed 2022-03-17 | $1.35M 10-K · filed 2022-03-17 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $833.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.12M 10-Q · filed 2021-11-10 | $1.12M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $833.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.12M 10-Q · filed 2021-08-12 | $1.12M derived: sum of 3 quarters · filed 2021-08-12 | $1.45M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $287.00K 10-Q · filed 2021-05-06 | $287.00K derived: sum of 2 quarters · filed 2021-05-06 | $612.00K derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $325.00K derived: sum of 2 quarters · filed 2021-03-04 | $1.18M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.18M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $850.00K 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |